Pharmacological Treatment of Dementia: Summary

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Unknown venue

• Publication date

  2004-04-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1037/e554762010-001
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Velnacrine for the treatment of Alzheimer's disease: A double-blind, placebo-controlled trial

  2005cited by this paper
• Scopolamine and the control of attention in humans

  2004cited by this paper
• Sustained improvement of cognition and global function in patients with moderately severe Alzheimer's disease: a double-blind, placebo-controlled study with the neurotrophic agent Cerebrolysin.

  2002cited by this paper
• Cerebrolysin in Alzheimer's disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent

  2002cited by this paper
• Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial.

  2002cited by this paper
• Estrogen and cognitive functioning in men with mild cognitive impairment

  2002cited by this paper
• Memory enhancement training for older adults with mild cognitive impairment: A preliminary study

  2002cited by this paper
• Comparison of Rapidly Acting Intramuscular Olanzapine, Lorazepam, and Placebo: A Double-blind, Randomized Study in Acutely Agitated Patients with Dementia

  2002cited by this paper
• Efficacy and Safety of Memantine in Patients With Mild to Moderate Vascular Dementia: A Randomized, Placebo-Controlled Trial (MMM 300)

  2002cited by this paper
• Donepezil‐Treated Patients with Probable Vascular Dementia Demonstrate Cognitive Benefits

  2002cited by this paper
• A 24‐week, double‐blind, placebo‐controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease—pilot study

  2002cited by this paper
• Safety and efficacy of idebenone versus tacrine in patients with Alzheimer's disease: results of a randomized, double-blind, parallel-group multicenter study.

  2002cited by this paper
• Randomized, double-blind, placebo-controlled international clinical trial of the Ampakine® CX516 in elderly participants with mild cognitive impairment

  2002cited by this paper
• Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients.

  2002cited by this paper
• Dementia caregiver intervention research: in search of clinical significance.

  2002cited by this paper
• A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500)

  2002cited by this paper
• A 28-week, double-blind, placebo-controlled study with Cerebrolysin in patients with mild to moderate Alzheimer's disease

  2001cited by this paper
• Nicergoline in the Treatment of Mild- to- Moderate Alzheimer's Disease

  2001cited by this paper
• High-dose estradiol improves cognition for women with AD

  2001cited by this paper
• A double‐blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients

  2001cited by this paper
• Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease.

  2001cited by this paper
• A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer’s disease

  2001cited by this paper
• A Randomized, Double‐Blind, Placebo‐Controlled Study of the Efficacy and Safety of Donepezil in Patients with Alzheimer's Disease in the Nursing Home Setting

  2001cited by this paper
• A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.

  2001cited by this paper
• Galantamine: a randomized, double‐blind, dose comparison in patients with Alzheimer's disease

  2001cited by this paper
• A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients

  2001cited by this paper
• Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial

  2001cited by this paper
• Donepezil, Rivastigmine, and Vitamin E in Alzheimer Disease: A Combined P300 Event-related Potentials/Neuropsychologic Evaluation over 6 Months

  2001cited by this paper
• Effects of estrogen on cognition, mood, and cerebral blood flow in AD

  2000cited by this paper
• A 5-month, randomized, placebo-controlled trial of galantamine in AD

  2000cited by this paper
• Double-blind, randomized, placebo-controlled pilot study with anapsos in senile dementia: effects on cognition, brain bioelectrical activity and cerebral hemodynamics.

  2000cited by this paper
• Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease: A Randomized Controlled Trial

  2000cited by this paper
• Double blind study of tiapride versus haloperidol and placebo in agitation and aggressiveness in elderly patients with cognitive impairment

  2000cited by this paper
• Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial

  2000cited by this paper
• A 1-year controlled trial of acetyl-l-carnitine in early-onset AD

  2000cited by this paper
• Efficacy of FPF 1070 (Cerebrolysin) in Patients with Alzheimer’s Disease

  2000cited by this paper
• Galantamine in AD

  2000cited by this paper
• A randomised, double‐blind comparison of the efficacy and safety of citalopram compared to mianserin in elderly, depressed patients with or without mild to moderate dementia

  2000cited by this paper
• Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study.

  2000cited by this paper
• Extended-release physostigmine in Alzheimer disease: a multicenter, double-blind, 12-week study with dose enrichment. Physostigmine Study Group.

  2000cited by this paper
• Estrogen for Alzheimer’s disease in women

  2000cited by this paper
• Efficacy and safety of nimodipine in subcortical vascular dementia: a subgroup analysis of the Scandinavian Multi-Infarct Dementia Trial.

  2000cited by this paper
• Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease.

  2000cited by this paper
• A Double‐Blind, Placebo‐Controlled, Multicenter Study of Cerebrolysin for Alzheimer's Disease

  2000cited by this paper
• Treatment of agitation in AD

  2000cited by this paper
• A phase II study in patients with Alzheimer's disease to assess the preliminary efficacy and maximum tolerated dose of rivastigmine (Exelon®)

  1999cited by this paper
• A Double-Blind, Placebo-Controlled Study of Tacrine in Chinese Patients with Alzheimer’s Disease

  1999cited by this paper
• Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trialCommentary: Another piece of the Alzheimer's jigsaw

  1999cited by this paper
• Double-Blind, Randomized, Placebo-Controlled Clinical Trial on the Efficacy and Tolerability of a Physostigmine Patch in Patients with Senile Dementia of the Alzheimer Type

  1999cited by this paper
• A 24-week randomized trial of controlled-release physostigmine in patients with Alzheimer’s disease

  1999cited by this paper
• A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia

  1999cited by this paper
• Memantine in severe dementia: results of the 9M‐best study (benefit and efficacy in severly demented patients during treatment with memantine)

  1999cited by this paper
• Estrogen therapy and aggressive behavior in elderly patients with moderate-to-severe dementia: results from a short-term, randomized, double-blind trial.

  1999cited by this paper
• The effects of metrifonate on the cognitive, behavioral, and functional performance of Alzheimer's disease patients. Metrifonate Study Group.

  1999cited by this paper
• Selegiline in the treatment of Alzheimer's disease: a long-term randomized placebo-controlled trial. Czech and Slovak Senile Dementia of Alzheimer Type Study Group.

  1999cited by this paper
• The Effects of Donepezil in Alzheimer’s Disease – Results from a Multinational Trial1

  1999cited by this paper
• Aminotransferase Levels and Silymarin in de novo Tacrine-Treated Patients with Alzheimer’s Disease

  1999cited by this paper
• The Efficacy of Cerebrolysin in Patients with Vascular Dementia: Results of a Chinese Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial

  1999cited by this paper
• Efficacy and safety of a loading-dose regimen versus a no-loading-dose regimen of metrifonate in the symptomatic treatment of Alzheimer's disease: A randomized, double-masked, placebo-controlled trial

  1999cited by this paper
• Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease

  1998cited by this paper
• L-deprenyl in Alzheimer's disease

  1998cited by this paper
• A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease

  1998cited by this paper
• Propentofylline enhances cerebral metabolic response to auditory memory stimulation in Alzheimer's disease.

  1998cited by this paper
• Sustained efficacy and safety of idebenone in the treatment of Alzheimer's disease: update on a 2-year double-blind multicentre study.

  1998cited by this paper
• Cholinesterase Inhibitors in the Treatment of Alzheimer’s Disease

  1998cited by this paper
• Metrifonate treatment of the cognitive deficits of Alzheimer's disease

  1998cited by this paper
• Donepezil Improves Cognition and Global Function in Alzheimer Disease A 15-Week, Double-blind, Placebo-Controlled Study

  1998cited by this paper
• Effects of metrifonate on cognitive decline in Alzheimer disease: a double-blind, placebo-controlled, 6-month study.

  1998cited by this paper
• Pharmacokinetics, Pharmacodynamics, and Safety of Metrifonate in Patients with Alzheimer's Disease

  1998cited by this paper
• EFFICACY AND TOLERABILITY OF RIVASTIGMINE IN PATIENTS WITH DEMENTIA OF THE ALZHEIMER TYPE

  1998cited by this paper
• Effectiveness and safety of posatirelin in the treatment of senile dementia: A multicenter, double-blind, placebo-controlled study

  1998cited by this paper
• A double‐blind comparison of the efficacy and safety of paroxetine and imipramine in the treatment of depression with dementia

  1998cited by this paper
• A 12-month, randomized, placebo-controlled trial of propentofylline (HWA 285) in patients with dementia according to DSM III-R. The European Propentofylline Study Group.

  1997cited by this paper
• A controlled study of 2 doses of idebenone in the treatment of Alzheimer's disease.

  1997cited by this paper
• Long-Term Nicergoline Treatment of Mild to Moderate Senile Dementia

  1997cited by this paper
• Posatirelin for the treatment of degenerative and vascular dementia: results of explanatory and pragmatic efficacy analyses.

  1997cited by this paper
• A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia

  1997cited by this paper
• A multicenter randomized double-blind study on the efficacy and safety of nicergoline in patients with multi-infarct dementia.

  1997cited by this paper
• Choto-san in the treatment of vascular dementia: a double-blind, placebo-controlled study.

  1997cited by this paper
• Measuring the efficacy of psychopharmacological treatment of psychomotoric restlessness in dementia: clinical evaluation of tiapride.

  1997cited by this paper
• Relations between symptomatology and brain function in dementias: double-blind, placebo-controlled, clinical and EEG/ERP mapping studies with nicergoline.

  1997cited by this paper
• Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type.

  1997cited by this paper
• A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

  1997cited by this paper
• Pilot study of haloperidol, fluoxetine, and placebo for agitation in Alzheimer's disease.

  1997cited by this paper
• A double-blind, placebo-controlled study of tacrine in patients with Alzheimer's disease using SPET

  1996cited by this paper
• European Pentoxifylline Multi-Infarct Dementia Study

  1996cited by this paper
• Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.

  1996cited by this paper
• A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease

  1996cited by this paper
• Therapeutic efficacy of vincamine in dementia.

  1996cited by this paper
• Posatirelin in the treatment of vascular dementia: a double‐blind multicentre study vs placebo

  1996cited by this paper
• Propentofylline improves regional cerebral glucose metabolism and neuropsychologic performance in vascular dementia.

  1996cited by this paper
• A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease

  1996cited by this paper
• The efficacy and safety of donepezil in patients with Alzheimer's disease: Results of a US multicentre, randomized, double-blind, placebo-controlled trial

  1996cited by this paper
• Double-Blind, Placebo-Controlled Study of Metrifonate, an Acetylcholinesterase Inhibitor, for Alzheimer Disease

  1996cited by this paper
• Nicergoline in senile dementia of alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study

  1995cited by this paper
• Pathophysiology and psychopharmacology of dementia--a new study design. I. Diagnosis comprising subjective and objective criteria.

  1995cited by this paper
• Posatirelin for the treatment of late‐onset Alzheimer's disease: a double‐blind multicentre study vs citicoline and ascorbic acid

  1995cited by this paper
• Superiority of Antagonic‐Stress Composition versus Nicergoline in Gerontopsychiatry

  1994cited by this paper
• Efficacy of tacrine and lecithin in mild to moderate Alzheimer's disease: double blind trial

  1994cited by this paper
• Idebenone, a new drug in the treatment of cognitive impairment in patients with dementia of the Alzheimer type.

  1994cited by this paper

• Computational Studies to Understand the Neuroprotective Mechanism of Action Basil Compounds

  2023cites this paper
• The efficacy of pharmacological interventions to improve cognitive and behavior symptoms in people with dementia: A systematic review and meta‐analysis

  2022cites this paper
• Dementia and Non-Pharmacological Interventions: Comparing Different Interventions and Agitation Levels

  2022cites this paper
• O USO DE JOGOS ELETRÔNICOS EM INTERVENÇÕES COM IDOSOS

  2020cites this paper
• Musical intervention for patients with dementia: a meta-analysis.

  2013cites this paper
• Effect of Musical Intervention in the Treatment of Behavioral, Psychological and Cognitive Problems in Patients with Dementia

  2011cites this paper
• Dementia Update 2005

  2005cites this paper